3YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Halometasone | 卤米松 | 50629-82-8 |
| Estradiol valerEstradiol valerateate | 戊酸雌二醇 | 979-32-8 |
| 葡萄糖酸 | 526-95-4 | |
| Ethinylestradiol Impurity 2 | 炔雌醇杂质2 | 5779-47-5 |
| 利格列汀杂质 | 216854-23-8 | |
| Estradiol Hemihydrate EP Impurity A;Estriol EP Impurity B ;Ethinylestradiol EP Impurity C;Estrone | 雌二醇半水合物EP杂质A；雌三醇EP杂质B；炔雌醇EP杂质C；雌酚酮 | 53-16-7 |
| Estradiol valerate EP impurity A;Ethinylestradiol EP Impurity D;Estriol EP Impurity D;Estradiol | 戊酸雌二醇EP杂质A；炔雌醇杂质D；雌三醇EP杂质D；雌二醇 | 50-28-2 |
| 16-Dehydropregnenolone acetate Impurity 2;Diosgenin | 醋酸妊娠双烯醇酮酯杂质2；薯蓣皂素 | 512-04-9 |
| Exemestane USP Impurity E+F | 依西美坦USP杂质E+F | 184972-12-1 |
| Exemestane Impurity C | 依西美坦USP杂质C | 1361017-89-1 |
| Nandrolone;Nandrolone Decanoate EP Impurity D | 诺龙；癸酸诺龙酮EP杂质D | 434-22-0 |
| Exemestane USP Impurity G | 依西美坦USP杂质G | 881896-95-3 |
| Exemestane Impurity 3 | 依西美坦杂质3 | 933455-73-3 |
| Deflazacort | 地夫可特 | 14484-47-0 |
| Cabozantinib impurity 42 | 卡博替尼杂质42 | 2840522-80-5 |
| Cabozantinib Impurity 28 | 卡博替尼杂质28 | 202917-05-3 |
| 伐地那非杂质 | 224787-06-8 | |
| Imatinib Impurity 25 | 伊马替尼杂质25 | 581076-60-0 |
| 泼尼松龙杂质15 | 3372-11-0 | |
| 立他司特杂质 | 2982988-09-8 | |
| 立他司特杂质26 | 2295862-29-0 | |
| Promestriene | 普罗雌烯 | 39219-28-8 |
| 16-Dehydropregnenolone acetate Impurity 1;Pregnenolone isobutyrate | 醋酸妊娠双烯醇酮酯杂质1；孕烯醇酮异丁酸酯 | |
| Imatinib Impurity 36 | 伊马替尼杂质36 | 1026194-04-6 |
| Dexamethasone acetate impurity | 醋酸地塞米松杂质9 | 134429-26-8 |
| Dabigatran etexilate | 达比加群酯 | 211915-06-9 |
| 西地那非杂质130；苄基西地那非 | 1446089-82-2 | |
| 西地那非杂质137；N-羟乙基哌嗪 | 103-76-4 | |
| 阿伐那非杂质25 | 1309798-84-2 | |
| Ticagrelor Impurity 55 | 替卡格雷杂质 55 | 2205903-72-4 |
| Clopidogrel EP Impurity B | 氯吡格雷EP杂质B | 2637140-93-1 |
| 西地那非杂质128；5-氯-2-乙氧基苯甲酸 | 62871-12-9 | |
| 利格列汀杂质 | 625471-18-3 | |
| D-(-)-2-CHLOROPHENYLGLYCINE METHYL ESTER HCL | (R)-邻氯苯甘氨酸甲酯盐酸盐 | 212838-70-5 |
| 西地那非杂质151；羟基卡巴地那非 | 2520113-14-6 | |
| 倍他米松杂质8 | 4451-48-3 | |
| 1885094-63-2 | ||
| (S)-methyl 2-(2-chlorophenyl)-2-(2-(hydroxymethyl)-6,7- dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate | 氯吡格雷杂质29 | 1346231-35-3 |
| 沃诺拉赞杂质 | 2932441-73-9 | |
| 阿伐那非杂质45；4-氯-2-甲硫基嘧啶-5-羧酸乙酯 | 5909-24-0 | |
| 奥拉西坦杂质 | 7491-74-9 | |
| 阿伐那非杂质38；3-氯-4-甲氧基苄胺盐酸盐 | 41965-95-1 | |
| 2-isobutoxy-5-(4-methylthiazol-2-yl)benzamide | 非布司他杂质 | 1863097-56-6 |
| 伐地那非杂质20；2-乙氧基苯甲脒盐酸盐 | 18637-00-8 | |
| 沃诺拉赞杂质 | 1883595-37-6 | |
| 塞来昔布中间体 | 720-94-5 | |
| Triamcinolone Acetonide Impurity | 曲安奈德杂质25 | 7704-77-0 |
| 泼尼松龙杂质15 | 118864-88-3 | |
| 4,4'-Dihydroxyazobenzene | 4,4-二羟基偶氮苯 | 2050-16-0 |
| Fluocinolone AcetonideImpurity 2 | 醋酸氟轻松杂质2 | 3093141-62-6 |
| 阿伐那非杂质36；阿伐那非中间体 | 330785-81-4 | |
| 伐地那非杂质22；1-脱羧-1-（溴乙酰基）去甲多巴那非 | 358388-58-6 | |
| 伐地那非杂质19 | 927690-90-2 | |
| 阿伐那非杂质37;BOC-L-脯氨醇 | 69610-40-8 | |
| 伐地那非杂质21；伐地那非中间体；伐地那非嘧啶酮 | 224789-21-3 | |
| 2-(2-thienyl)ethyl toluene-p-sulphonate | 2-(噻吩-2-基)乙基对甲苯磺酸酯 | 40412-06-4 |
| 倍他米松杂质 24 | 1203841-43-3 | |
| 西地那非杂质150 | 2725318-34-1 | |
| Cabozantinib | 卡博替尼 | 849217-68-1 |
| 阿伐那非杂质39； 2-氯嘧啶 | 1722-12-9 | |
| Cabozantinib Impurity 27 | 卡博替尼杂质27 | 190728-26-8 |
| (S)-5-((S)-1-(2-chlorophenyl)-2methoxy-2-oxoethyl)-5-hydroxy-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-ium | 氯吡格雷氮氧化物 | 2711084-94-3 |
| 2-(((3aS,4R,6S,6aR)-6-amino-2,2-dimethyltetrahydro-4Hcyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol (2S,3S)-2,3-dihydroxysuccinate | TGRL020 | 2376278-72-5 |
| 他达那非杂质25；他达那非杂质中间体 | 171752-68-4 | |
| 利格列汀杂质14 | 2518331-40-1 | |
| 胆固醇EP杂质A | 80-99-9 | |
| Chenodeoxycholic acid EP Impurity A;Ursodeoxycholic acid | 鹅去氧胆酸EP杂质A;熊去氧胆酸 | 128-13-2 |
| 注射用胆固醇EP杂质F;胆固醇醋酸酯 | 604-35-3 | |
| Thiothiamine;Thiamine EP Impurity E | 硫代硫胺素；盐酸硫胺素EP杂质E | 299-35-4 |
| Fluocinolone Acetonide EP Impurity I | 醋酸氟轻松EP杂质I | |
| Ticagrelor Impurity 68 | 替卡格雷杂质68 | 1006376-62-0 |
| Ursodeoxycholic Acid EP Impurity C;Chenodeoxycholic Acid EP Impurity C;Lithocholic acid | 熊去氧胆酸EP杂质C; 鹅去氧胆酸EP杂质C; 石胆酸 | 434-13-9 |
| 3-(4-Methyl-piperazin-1-ylmethyl)-benzoic acid | 3-(4-甲基-哌嗪-1-基甲基)-苯甲酸 | 514209-42-8 |
| Imatinib Impurity 18 | 伊马替尼杂质18 | 1181636-34-9 |
| 罗西替尼杂质5 | 1548527-26-9 | |
| 胆固醇杂质7；25-羟脱氢胆固醇 | 22145-68-2 | |
| Urosodeoxycholic Acid EP Impurity A; Chenodeoxycholic acid | 熊去氧胆酸EP杂质A;鹅去氧胆酸 | 474-25-9 |
| 注射用胆固醇EP杂质D;β-谷甾醇 | 83-46-5 | |
| 胆固醇杂质4;7-去氢胆固醇 | 434-16-2 | |
| 4-Amino-N-methylaniline | N-甲基对苯二胺 | 5395-70-0 |
| Deoxycholic Acid Impurity | 去氧胆酸乙二醇酯 | 1005791-24-1 |
| 醋酸泼尼松龙杂质7 | 96709-31-8 | |
| Imatinib Impurity 20 | 伊马替尼杂质20 | 1513934-33-2 |
| Ticagrelor Impurity J | 替格瑞洛杂质J | 2248538-63-6 |
| CLOPIDOGREL CARBOXYLIC ACID | 氯吡格雷酸 | 144457-28-3 |
| Vildagliptin Impurity 17 | 维格列汀杂质17 | 2381862-94-6 |
| hydrogen 2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl sulfate | 替格瑞洛磺酸酯 | 2435586-33-5 |
| 泼尼松龙杂质8 | 96168-87-5 | |
| Ticagrelor Impurity 71 | 替卡格雷杂质71 | 2205903-75-7 |
| 阿伐那非杂质49 | 1452128-53-8 | |
| 胆固醇杂质6；25-羟基胆甾醇 | 2140-46-7 | |
| Febuxostat Impurity 130 | 非布司他二乙酯 | 1643131-93-4 |
| Vildagliptin Impurity 12 | 维格列汀杂质12 | 2253194-12-4 |
| (+)-α-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)-α-2-chlorophenylacetamide | S-氯吡格雷酰胺 | 444728-13-6 |
| 阿伐那非杂质46 | 2221018-00-2 | |
| Ticagrelor Impurity 21 | 替格瑞洛杂质21 | 2512210-21-6 |
| 利格列汀杂质58 | 2444011-29-2 | |
| 伊多塞班杂质14 | 2752546-54-4 | |
| 胆固醇杂质1;二氢胆固醇 | 80-97-7 | |
| (1S,2R)-2-(3,4-Difluorophenyl)-cyclopropanaMine | (1S,2R)-2-(3,4-二氟苯基)-环丙胺 | 1345413-20-8 |
联系方式
